With Steris established as a trustworthy sterilization provider, it also benefits from traces of intangible assets. Hospitals can ill afford to use devices that haven’t been effectively sterilized, ...

Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major ...

STERIS plc STE rides on the robust performance of its Healthcare business.The company also benefits from the strong rebound prospects for its Applied Sterilization Technologies (“AST”) segment.

Steris, headquartered in Ireland, is a dominant force in medical device sterilization, sterilizing one third of all medical devices in the world. Because it offers a full suite of sterilization ...

Steris offers comprehensive sterilization and disinfection portfolios to healthcare providers, with 80% of their revenue being recurring. The company has a strong presence in the Applied Sterilization ...

STERIS will host a conference call to discuss its fiscal 2025 third quarter financial results, demonstrating transparency and engagement with investors. A press release detailing the financial results ...